Navigation Links
Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results
Date:4/1/2008

WARSAW, Ind., April 1, 2008 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today its first quarter 2008 sales and earnings conference call will be broadcast live over the Internet on Thursday, April 24, 2008, at 8:00 a.m. Eastern Time. A news release detailing the quarterly results will be made available at 7:00 a.m. the morning of the conference call.

The live audio webcast can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. It will be archived for replay following the conference.

Individuals who wish to dial into the conference call may do so at (888) 815-6162. International callers should dial (706) 634-9502. A digital recording will be available two hours after the completion of the conference call from April 24, 2008 to May 4, 2008. To access the recording, US/Canada callers should dial (800) 642-1687, or for International callers, dial (706) 645-9291, and enter the Conference ID, 41904442.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is a worldwide leader in designing, developing, manufacturing and marketing orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2007 sales were approximately $3.9 billion. The Company is supported by the efforts of more than 7,500 employees worldwide.

Visit Zimmer on the worldwide web at http://www.zimmer.com.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Zimmer Holdings to Present at Upcoming Investor Conferences
2. Zimmer to Expand Manufacturing Network
3. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
4. Zimmer Reports Fourth Quarter and 2007 Financial Results
5. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
6. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
7. Zimmer Holdings to Present at JPMorgan Healthcare Conference
8. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
9. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
10. Zimmer Holdings to Present at Upcoming Investor Conferences
11. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingme...iorsinthegreaterLongBeachareathankstoFaithInAction...denceatHome(IAH),adivisionofSCANHealthPlan.Formore...fvolunteerstodeliverwarmThanksgivingmealstoseniors...thLosAngelesandsurroundingcities. ,, "Ourwarmho...
(Date:11/25/2009)...ANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQuali...er Spare the Air Alert forThursday,N...elogsoranyothersolidfuel,bothindoorsandoutdoors. ,...rqualitytomorrow,"saidJackBroadbent,executiveoffic...espectthehealthoftheirneighborsandfellowcommunitym...
(Date:11/25/2009)...hers have found evidence of a statistically signif...ng patients whose estrogen receptor (ER)-positive ...pha; at serine-118 (ER-alpha S118-P), according to...5 in the Journal of the National Cancer Institute...resistant to tamoxifen. Preclinical studies have s...
(Date:11/25/2009)... follow-up period was too short to draw definite c... Nov. 25 (HealthDay News) -- In diabetic patients ...e no difference in outcomes at one year whether pa...stenting, British researchers report. , Bypass ...ic patients with coronary artery disease. However,...
(Date:11/25/2009)...forgetfulness could lead mothers to overlook neede...25 (HealthDay News) -- A mother,s depression can w...und. , Their six-month study of 262 black mothe...thers had more depressive symptoms had more freque... fewer depressive symptoms had less frequent asthm...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2
... 18 Sales leaders and,organizations that regularl...e art of motivating their sales representatives. O... sales personnel can use the key findings,discover... Best Practices, LLC conducted this benchmark stud...
...e following is being,issued by the American Hospit...nd Coalition of Full Service Community Hospitals:,... self-referral and the,conflict of interest it cre...ssed a ban on physician self-referral to,hospitals...
...ght now, about half of all people who take medicin...it. And doctors have no definitive way to predict ...iety prescription they write. , But a University...ing the connection between brain activity, genetic...
...8 QMed, Inc.,(Nasdaq: QMED ) today announced tha...ter dated April 14, 2008, notifying the Company th...e 4350(i)(1)(A) due to its,failure to comply with ...eting the financing in violation of shareholder,ap...
... diminished depression almost as much as drug trea...s) -- Talk therapy can help treat depression sympt... Japanese researchers who reviewed the results of ... was supportive expressive group therapy, in which...
...foods have staying power,according to a new report...he U.S. The soy food and beverage market topped $2...snack bar and soymilk products. Sales of soy,foods...gh 2012, rounding out at $3 billion., Having been...
Other Medicine News:Health News:Complementary Excerpt Available from Best Practices: Rewarding and Recognizing Top-Performing Sales People 2Health News:Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities 2Health News:High anxiety? 2Health News:High anxiety? 3Health News:High anxiety? 4Health News:QMed, Inc. Receives NASDAQ Delisting Letter 2Health News:QMed, Inc. Receives NASDAQ Delisting Letter 3Health News:Talk Therapy Proves Effective for Terminal Cancer Patients 2Health News:Soy Foods Beat Out Fresh Fish and Meat for 'Best New Products Tried By Consumers' While Demand and Profits Continue to Grow 2
(Date:11/25/2009)...irstCall/--AmericanScientificResourcesInc.(PinkShe...haveopenedaregionalmarketingandproductionmanagemen...urealocationabroad,providinganessentialgatewayfort...andsafetyproductsforchildrenandadultstobedistribut...ryinthestateofOhiowheretheywillalsobeabletodosubco...
(Date:11/25/2009)...5/PRNewswire/-- FromNovember16-18,Phonak,theleadin...dthesecondeditionoftheHearingCareforAdultsConferen...heconferencebroughttogetherleadingexpertsinagingan...nswhoworkeverydaywitholderpeoplewithhearinglossfor...researchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...swire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAm...daythatitreceivedtheEnvironmentalResponsibilityand...alSummit,sponsoredbytheCaliforniaManufacturersandT...talAssociation(IEA)andtheChemicalIndustryCouncilof...giousawardavailablefromallthreeorganizationsandgai...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 1Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 3Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 1Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 1PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 3PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 4
...he Treatment of Inflammatory ...Payment from Partner GlaxoSmithKline, MOUNTAIN VI...unced the initiation of a Phase I clinical trial o...e compound designed to specifically,target the CCR...ammatory,diseases such as rheumatoid arthritis. Wi...
...i Corporation (,Iomai,) in a, fully recommended sh...ai,s common stock representing a fully diluted e...llion (EUR 122 million). Acquisition to be, accomp...imately 41 percent of Iomai,s current shares outs...ly 1.7 million Intercell shares (representing appr...
Other Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11
Basic modular VICTOR2 Multilabel Counter (3 technologies)
Manual VICTOR2 with fluorescence, fluorescence polarization and luminescence technologies
VICTOR2 V (5 technologies) with stackers and robotic loading
VICTOR2 multilabel counter with IR, high density TR-fluorometry, stacker and robot loading
Medicine Products: